Efficacy of Purslane in Treatment of Oral Lichen Planus

Status Completed

Clinical Trial Summary

Oral lichen planus (OLP) is a chronic inflammatory disease whose prevalence in the general population is 0.5 -2.2%.Oral lesions in OLP are chronic, rarely undergo spontaneous remission. Patients with OLP had significantly increased risk of oral squamous cell carcinoma, irrespective of the clinical type of OLP and therapy. there is currently no cure for OLP. Previous study demonstrated a decreased antioxidant defence and increased oxidative damage to lipids.DNA and proteins in lichen planus. This oxidative modifications point to pathophysiological alterations mainly within the basal cell layers of epidermis and at the dermoepidermal junction. Purslane is an excellent source of vitamin A,C and E and essential amino acids, has been described as a power food of the future because of its high nutritive and antioxidant properties. The purpose of the study was to determined the efficacy of Purslane in the treatment of oral lichen planus.

Clinical Trial Description

Oral lichen planus is a chronic common inflammatory disorder affecting stratified squamous epithelia. The majority problem of OLP is development of oral squamous cell carcinoma , irrespective of the clinical type of OLP and therapy. Previous study demonstrated a decreased antioxidant defence and increased oxidative damage to lipids, DNA and proteins in lichen planus .This oxidative modifications point to pathophysiological alterations mainly within the basal cell layers of epidermis and at the dermoepidermal junction. So oxidative stress could be effective in pathogenesis of OLP. Purslane is an excellent source of vitamin A,C and E and essential amino acids, has been described as a power food of the future because of its high nutritive and antioxidant properties. Purslane also decreased the level of TNF-α and IL6, that are responsible for up-regulated adhesion molecules (in OLP lymphocyte T (T cell) recruited and retained in sub mucosa through receptors to endothelial adhesion molecule. and basal keratinocytes undergo apoptosis). The purpose of the study was to determined the efficacy of Purslane in the treatment of oral lichen planus. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00746772
Study type	Interventional
Source	Qazvin University Of Medical Sciences
Contact
Status	Completed
Phase	Phase 2
Start date	April 2006
Completion date	August 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03320460` - Photobiomodulation in Oral Lichen Planus	N/A
Completed	`NCT02276573` - Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus	N/A
Recruiting	`NCT06158113` - Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study	Phase 2
Completed	`NCT03687437` - Lichen Planus and Mean Platelet Volum
Completed	`NCT00130572` - Efficacy of Elidel Cream on Erosive Oral Lichen Planus	Phase 3
Completed	`NCT04673916` - Treatment Protocols for Patients With Symptomatic Oral Lichen Planus	N/A
Not yet recruiting	`NCT06362005` - The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus	Phase 4
Completed	`NCT00133107` - Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus	N/A
Completed	`NCT00102557` - Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus	Phase 2
Completed	`NCT04718311` - Study on Treatment for Patients With Symptomatic Oral Lichen Planus	N/A
Recruiting	`NCT05330572` - Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
Completed	`NCT00656214` - Treatmant of Oral Lichen Planus With Lycopene	Phase 2
Completed	`NCT04976673` - Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.